Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression

Glioblastoma multiforme (GBM) is the most aggressive type of primary brain tumor. GBM growth dynamics vary widely across patients, making it difficult to accurately gauge their response to treatment. We developed a model-based metric of therapy response called Days Gained that accounts for this hete...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Neal, Maxwell Lewis, Trister, Andrew D., Ahn, Sunyoung, Baldock, Anne, Bridge, Carly A., Guyman, Laura, Lange, Jordan, Sodt, Rita, Cloke, Tyler, Lai, Albert, Cloughesy, Timothy F., Mrugala, Maciej M., Rockhill, Jason K., Rockne, Russell C., Swanson, Kristin R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740772/
https://ncbi.nlm.nih.gov/pubmed/23400596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-3588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados